{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:32:57Z","timestamp":1773833577343,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"SeaStar Medical"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Streptococcal toxic shock syndrome (STSS) is a fulminant complication of predominantly invasive group A streptococcal infections. STSS is often characterized by influenza-like symptoms, including fever, chills, and myalgia that can quickly progress to sepsis with hypotension, tachycardia, tachypnea, and multiple organ failure (kidney, liver, lung, or blood). Mortality can exceed 50% depending on the severity of symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CASE SUMMARY:<\/jats:title>\n            <jats:p>Here, we describe a novel, multi-extracorporeal intervention strategy in a case of severe septic shock secondary to STSS. A 28-year-old woman 5 days after cesarean section developed STSS with respiratory distress, hypotension, and multiple organ failure. Despite conventional therapy with intubation, antibiotics, vasopressors, and fluid resuscitation, her condition worsened. She was placed on venoarterial extracorporeal membrane oxygenation (VA-ECMO) with subsequent initiation of pathogen hemoperfusion using the Seraph 100 blood filter, followed by immunomodulation with the selective cytopheretic device (SCD). No device-related adverse events were observed. The patient\u2019s condition gradually stabilized with discontinuation of vasopressors after 4 days, ECMO decannulation after 6 days, evidence of renal recovery after 7 days, and extubation from mechanical ventilation after 14 days. She was transferred to conventional hemodialysis after 13 days and discontinued all kidney replacement therapy 11 days later.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>This is the first reported use of VA-ECMO, Seraph 100 hemoperfusion, and cell-directed immunomodulation with SCD. This multimodal approach to extracorporeal support represents a promising therapeutic strategy for the most refractory critical care cases. Further studies are needed to assess the safety and efficacy of this sequential approach.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001058","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T16:01:09Z","timestamp":1708963269000},"page":"e1058","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Sequential Extracorporeal Therapy of Pathogen Removal Followed by Cell-Directed Extracorporeal Therapy in Streptococcal Toxic Shock Syndrome Refractory to Venoarterial Extracorporeal Membrane Oxygenation: A Case Report"],"prefix":"10.1097","volume":"6","author":[{"given":"Stephen J.","family":"Amerson","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, The Institute for Extracorporeal Life Support and Texas Intensivist, Pulmonary, and Sleep Medicine, San Antonio, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"McKenna","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Institute for Extracorporeal Life Support and Texas Intensivist, Pulmonary, and Sleep Medicine, San Antonio, TX."},{"name":"Department of Internal Medicine, Methodist Healthcare System of San Antonio Ltd, San Antonio, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Abouzahr","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, Renal Associates PA, San Antonio, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, San Antonio Kidney Disease Center, San Antonio, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel K.","family":"Sterling","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Institute for Extracorporeal Life Support and Texas Intensivist, Pulmonary, and Sleep Medicine, San Antonio, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitesh","family":"Gidwani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Institute for Extracorporeal Life Support and Texas Intensivist, Pulmonary, and Sleep Medicine, San Antonio, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda E.","family":"Sousse","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Institute for Extracorporeal Life Support and Texas Intensivist, Pulmonary, and Sleep Medicine, San Antonio, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Dellavolpe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Institute for Extracorporeal Life Support and Texas Intensivist, Pulmonary, and Sleep Medicine, San Antonio, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"R1-20240806","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13613-018-0438-y","article-title":"Streptococcal toxic shock syndrome in the intensive care unit.","volume":"8","author":"Schmitz","year":"2018","journal-title":"Ann Intensive Care"},{"key":"R2-20240806","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/cid\/ciw248","article-title":"Epidemiology of invasive group A streptococcal infections in the United States, 2005-2012.","volume":"63","author":"Nelson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R3-20240806","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/521264","article-title":"The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.","volume":"45","author":"O\u2019Loughlin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R5-20240806","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13054-023-04310-2","article-title":"Rationale for sequential extracorporeal therapy (SET) in sepsis.","volume":"27","author":"Ronco","year":"2023","journal-title":"Crit Care"},{"key":"R6-20240806","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3390\/biomedicines10082017","article-title":"The supporting role of combined and sequential extracorporeal blood purification therapies in COVID-19 patients in intensive care unit.","volume":"10","author":"Nalesso","year":"2022","journal-title":"Biomedicines"},{"key":"R7-20240806","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000508647","article-title":"Heparin 2.0: A new approach to the infection crisis.","volume":"50","author":"Seffer","year":"2021","journal-title":"Blood Purif"},{"key":"R8-20240806","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13054-023-04492-9","article-title":"Efficacy of CytoSorb\u00ae: A systematic review and meta-analysis.","volume":"27","author":"Becker","year":"2023","journal-title":"Crit Care"},{"key":"R9-20240806","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ndt\/gfab347","article-title":"Interim analysis of the COSA (COVID-19 patients treated with the Seraph\u00ae 100 Microbind\u00ae Affinity filter) Registry.","volume":"37","author":"Schmidt","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"R10-20240806","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3325\/cmj.2023.64.284","article-title":"Enterobacter cloacae septicemia in a triple-cannula extracorporeal membrane oxygenation circulatory support treated with Seraph-100 Microbind affinity blood filter.","volume":"64","author":"Pavlov","year":"2023","journal-title":"Croat Med J"},{"key":"R11-20240806","doi-asserted-by":"crossref","first-page":"e2670","DOI":"10.1093\/milmed\/usad063","article-title":"Single-center experience with the Seraph-100\u00ae Microbind\u00ae affinity blood filter in patients with SARS-CoV-2 infection and septic shock at a military treatment facility.","volume":"188","author":"Stoffel","year":"2023","journal-title":"Mil Med"},{"key":"R12-20240806","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000245645","article-title":"A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure.","volume":"29","author":"Humes","year":"2010","journal-title":"Blood Purif"},{"key":"R13-20240806","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/MAT.0b013e31820a1494","article-title":"The effects of a novel therapeutic device on acute kidney injury outcomes in the intensive care unit: A pilot study.","volume":"57","author":"Ding","year":"2011","journal-title":"ASAIO"},{"key":"R14-20240806","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/sdi.12032","article-title":"The effect of the selective cytopheretic device on acute kidney injury outcomes in the intensive care unit: A multicenter pilot study.","volume":"26","author":"Tumlin","year":"2013","journal-title":"Semin Dial"},{"key":"R15-20240806","doi-asserted-by":"crossref","first-page":"e0132482","DOI":"10.1371\/journal.pone.0132482","article-title":"A multi-center, randomized, controlled, pivotal study to assess the safety and efficacy of a selective cytopheretic device in patients with acute kidney injury.","volume":"10","author":"Tumlin","year":"2015","journal-title":"PLoS One"},{"key":"R16-20240806","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ekir.2020.12.010","article-title":"Use of the selective cytopheretic device in critically ill children.","volume":"6","author":"Goldstein","year":"2021","journal-title":"Kidney Int Rep"},{"key":"R18-20240806","doi-asserted-by":"crossref","first-page":"e0694","DOI":"10.1097\/CCE.0000000000000694","article-title":"Extracorporeal immunomodulation treatment and clinical outcomes in ICU COVID-19 patients.","volume":"4","author":"Yessayan","year":"2022","journal-title":"Crit Care Explor"},{"key":"R19-20240806","first-page":"e027","article-title":"Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in human.","volume":"18","author":"Humes","year":"3138","journal-title":"PLoS One"},{"key":"R20-20240806","doi-asserted-by":"crossref","first-page":"e0995","DOI":"10.1097\/CCE.0000000000000995","article-title":"Safety summary of the selective cytopheretic device: A review of the safety data across multiple clinical trials in ICU patients with acute kidney injury and multiple organ failure.","volume":"5","author":"Humes","year":"2023","journal-title":"Crit Care Explor"},{"key":"R21-20240806","doi-asserted-by":"crossref","first-page":"e34680","DOI":"10.1097\/MD.0000000000034680","article-title":"Venoarterial extracorporeal membrane oxygenation for group B streptococcal toxic shock syndrome: A case report and literature review.","volume":"102","author":"Iwasaki","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"R22-20240806","doi-asserted-by":"crossref","first-page":"19895","DOI":"10.1074\/jbc.M801614200","article-title":"Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock.","volume":"283","author":"Hayashida","year":"2008","journal-title":"J Biol Chem"},{"key":"R23-20240806","doi-asserted-by":"crossref","first-page":"628302","DOI":"10.3389\/fmed.2021.628302","article-title":"Sepsis\u2014pathophysiology and therapeutic concepts.","volume":"8","author":"Jarczak","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R24-20240806","doi-asserted-by":"crossref","first-page":"963955","DOI":"10.3389\/fimmu.2022.963955","article-title":"Dysregulation of neutrophil death in sepsis.","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T23:03:09Z","timestamp":1722985389000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001058","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]}}}